Yesterday as you are aware, AbbVie Stock (ABBV) fell on news that the company planned to buy out Allergen for $63 billion of cash and stock. Allergan’s shares popped 26% while AbbVie shares fell 15%.
I entered some repairs yesterday. Here are a few more repairs done today as I continue to generate profits despite the collapse of AbbVie Stock (ABBV).
More On AbbVie Stock (ABBV) Trades and Repairs – Jun 26 2019
Disclaimer: There are risks involved in all investment strategies and investors can and do lose capital. Trade at your own risk.
Internal Stock and Option Trades Links